6:05 AM ET
8-K
Executive Compensation
Abbott Laboratories Executive Compensation
Abbott Laboratories extended the term of its Change in Control Agreements for its named executive officers through December 31, 2028. The agreement for Chairman and CEO Robert B. Ford was not extended and is set to expire on December 31, 2026.
- Term
- through Dec 2028